INDIA will allow the export of cough syrups only after samples are tested in a government laboratory, a government notice declared yesterday, after Indian-made cough syrups were linked to the deaths of some children in Gambia and Uzbekistan.
Any cough syrup must have a certificate of analysis issued by a govt laboratory before it is exported, effective 01 Jun, the government said in a notice.
"Cough syrup shall be permitted to be exported subject to the export sample being tested and production of certificate of analysis," the notice issued by the country's trade ministry stated.
Indian-made cough syrups were linked to the deaths of 70 children in Gambia and 19 in Uzbekistan last year, denting the image of India's US $41 billion (A$61.67 billion) pharmaceutical industry.
India was also considering a change to its pharmaceutical industry policy.
The above article was sent to subscribers in Pharmacy Daily's issue from 24 May 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 May 23
